Yazar "Valenti, Luca" için listeleme
-
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Zhang, Huai; Targher, Giovanni; Byrne, Christopher D.; Kim, Seung Up; Wong, Vincent Wai-Sun; Valenti, Luca; Glickman, Myer; Ponce, Jaime; Mantzoros, Christos S.; Crespo, Javier; Gronbaek, Henning; Yang, Wah; Eslam, Mohammed; Wong, Robert J.; Machado, Mariana Verdelho; Yu, Ming-Lung; Ghanem, Omar M.; Okanoue, Takeshi; Liu, Jun-Feng; Lee, Yong-Ho; Xu, Xiao-Yuan; Pan, Qiuwei; Sui, Meili; Lonardo, Amedeo; Yılmaz, Yusuf; Zhu, Li-Yong; Moreno, Christophe; Miele, Luca; Lupsor-Platon, Monica; Zhao, Lei; LaMasters, Teresa LeAnn; Gish, Robert G.; Nedelcu, Marius; Chan, Wah Kheong; Xia, Ming-Feng; Bril, Fernando; Shi, Jun-Ping; Datz, Christian; Romeo, Stefano; Sun, Jian; Liu, Dan; Sookoian, Silvia; Mao, Yi-Min; Méndez-Sánchez, Nahum; Wang, Xiao-Yan; Pyrsopoulos, Nikolaos T.; Fan, Jian-Gao; Fouad, Yasser; Sun, Dan-Qin; Giannini, Cosimo; Chai, Jin; Xia, Ze-Feng; Jun, Dae Won; Li, Guo-Jing; Treeprasertsuk, Sombat; Li, Ying-Xu; Zhang, Faming; Goh, George Boon-Bee; Furuhashi, Masato; Seto, Wai-Kay; Huang, Hui; Di Sessa, Anna; Li, Qing-Hong; Cholongitas, Evangelos; Zhang, Le; Silveira, Themis Reverbel; Sebastiani, Giada; Adams, Leon A.; Chen, Wei; Qi, Xiaolong; Rankovic, Ivan; De Ledinghen, Victor; Lv, Wen-Jie; Hamaguchi, Masahide; Kassir, Radwan; Müller-Wieland, Dirk; Romero-Gomez, Manuel; Xu, Ying; Xu, Yi-Cong; Chen, Shi-Yao; Kermansaravi, Mohammad; Kuchay, Mohammad Shafi; Lefere, Sander; Parmar, Chetan; Lip, Gregory Y. H.; Liu, Chun-Jen; Åberg, Fredrik; Lau, George; George, Jacob; Sarin, Shiv Kumar; Zhou, Jing-Ya; Zheng, Ming-Hua (Springer, 2024)Background: With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, ... -
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
Sun, Dan-Qin; Targher, Giovanni; Byrne, Christopher D.; Wheeler, David C.; Wong, Vincent Wai-Sun; Fan, Jian-Gao; Tilg, Herbert; Yuan, Wei-Jie; Wanner, Christoph; Gao, Xin; Long, Michelle T.; Kanbay, Mehmet; Nguyen, Mindie H.; Navaneethan, Sankar D.; Yılmaz, Yusuf; Huang, Yuli; Gani, Rino A.; Marzuillo, Pierluigi; Boursier, Jerome; Zhang, Huijie; Jung, Chan-Young; Chai, Jin; Valenti, Luca; Papatheodoridis, George; Musso, Giovanni; Wong, Yu-Jun; El-Kassas, Mohamed; Mendez-Sanchez, Nahum; Sookoian, Silvia; Pavlides, Michael; Duseja, Ajay; Holleboom, Adriaan G.; Shi, Junping; Chan, Wah-Kheong; Fouad, Yasser; Yang, Junwei; Treeprasertsuk, Sombat; Cortez-Pinto, Helena; Hamaguchi, Masahide; Romero-Gomez, Manuel; Al Mahtab, Mamun; Ocama, Ponsiano; Nakajima, Atsushi; Dai, Chunsun; Eslam, Mohammed; Wei, Lai; George, Jacob; Zheng, Ming-Hua (AME Publishing Company, 2023)Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In ... -
A multi-society Delphi consensus statement on new fatty liver disease nomenclature
Rinella, Mary, E.; Lazarus, Jeffrey V.; Ratziu, Vlad; Francque, Sven M.; Sanyal, Arun J.; Kanwal, Fasiha; Romero, Diana; Abdelmalek, Manal; Anstee, Quentin M.; Arab, Juan Pablo; Arrese, Marco; Bataller, Ramon; Beuers, Ulrich; Boursier, Jerome; Bugianesi, Elisabetta; Byrne, Christopher D.; Castro Narro, Graciela E.; Chowdhury, Abhijit; Cortez-Pinto, Helena; Cryer, Donna; Cusi, Kenneth; El-Kassas, Mohamed; Klein, Samuel; Eskridge, Wayne; Fan, Jiangao; Gawrieh, Samer; Guy, Cynthia D.; Harrison, Stephen A.; Kim, Seung Up; Koot, Bart; Korenjak, Marko; Kowdley, Kris; Lacaille, Florence; Loomba, Rohit; Mitchell Thain, Robert; Morgan, Timothy R.; Powell, Elisabeth; Roden, Michael; Romero-Gomez, Manuel; Silva, Marcelo; Prasad Singh, Shivaram; Sookoian, Silvia C.; Spearman, C. Wendy; Tiniakos, Dina; Valenti, Luca; Vos, Miriam B.; Wong, Vincent Wai-Sun; Xanthakos, Stavra; Yılmaz, Yusuf; Younossi, Zobair; Hobbs, Ansley; Villota-Rivas, Marcela; Newsome, Philip N.; NAFLD Nomenclature consensus group (Elsevier, 2023)The principal limitations of the terms nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. ... -
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, Mary E.; Lazarus, Jeffrey V.; Ratziu, Vlad; Francque, Sven M.; Sanyal, Arun J.; Kanwal, Fasiha; Romero, Diana; Abdelmalek, Manal F.; Anstee, Quentin M.; Arab, Juan Pablo; Arrese, Marco; Bataller, Ramon; Beuers, Ulrich; Boursier, Jerome; Bugianesi, Elisabetta; Byrne, Christopher D.; Castro Narro, Graciela E.; Chowdhury, Abhijit; Cortez-Pinto, Helena; Cryer, Donna R.; Cusi, Kenneth; El-Kassas, Mohamed; Klein, Samuel; Eskridge, Wayne; Fan, Jiangao; Gawrieh, Samer; Guy, Cynthia D.; Harrison, Stephen A.; Kim, Seung Up; Koot, Bart G.; Korenjak, Marko; Kowdley, Kris V.; Lacaille, Florence; Loomba, Rohit; Mitchell-Thain, Robert; Morgan, Timothy R.; Powell, Elisabeth E.; Roden, Michael; Romero-Gómez, Manuel; Silva, Marcelo; Singh, Shivaram Prasad; Sookoian, Silvia C.; Spearman, C. Wendy; Tiniakos, Dina; Valenti, Luca; Vos, Miriam B.; Wong, Vincent Wai-Sun; Xanthakos, Stavra; Yılmaz, Yusuf; Younossi, Zobair; Hobbs, Ansley; Villota-Rivas, Marcela; Newsome, Philip N. (Elsevier, 2023)The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient ... -
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
Lazarus, Jeffrey V.; Castera, Laurent; Mark, Henry E.; Allen, Alina M.; Adams, Leon A.; Anstee, Quentin M.; Arrese, Marco; Alqahtani, Saleh A.; Bugianesi, Elisabetta; Colombo, Massimo; Cusi, Kenneth; Hagström, Hannes; Loomba, Rohit; Romero-Gomez, Manuel; Schattenberg, Jörn M.; Thiele, Maja; Valenti, Luca; Wai-Sun Wong, Vincent; Yılmaz, Yusuf; Younossi, Zobair M.; Francque, Sven M.; Tsochatzis, Emmanuel A. (Elsevier, 2022)Background & Aims: Non-invasive tests (NITs) offer a practical solution for advanced fibrosis identification in non-alcoholic fatty liver disease (NAFLD). Despite increasing implementation, their use is not standardised, ... -
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
Feng, Gong; Valenti, Luca; Wong, Vincent Wai-Sun; Fouad, Yasser Mahrous; Yılmaz, Yusuf; Kim, Won; Sebastiani, Giada; Younossi, Zobair M.; Hernandez Gea, Virginia; Zheng, Ming-Hua (SpringerNature, 2023)Recompensation has gained increasing attention in the feld of cirrhosis, particularly in chronic liver disease with a defnite aetiology. The current global prevalence of obesity and nonalcoholic fatty liver disease (NAFLD) ... -
Resmetirom and metabolic dysfunction-associated steatohepatitis: Perspectives on multidisciplinary management from global healthcare professionals
Au, Kahei; Zheng, Ming-Hua; Lee, Wei-Jei; Ghanem, Omar M.; Mahawar, Kamal; Shabbir, Asim; le Roux, Carel W.; Targher, Giovanni; Byrne, Christopher D.; Yılmaz, Yusuf; Valenti, Luca; Sebastiani, Giada; Treeprasertsuk, Sombat; Hui, Hannah Xiaoyan; Sakran, Nasser; Neto, Manoel Galvao; Kermansaravi, Mohammad; Kow, Lilian; Seki, Yosuke; Tham, Kwang Wei; Dang, Jerry; Cohen, Ricardo V.; Stier, Christine; Alsabah, Salman; Oviedo, Rodolfo J.; Chiappetta, Sonja; Parmar, Chetan; Yang, Wah (Springer, 2024)Purpose of ReviewThe approval of resmetirom brings great hope to patients with metabolic dysfunction-associated steatohepatitis (MASH). The purpose of this review is to explore its impact on the global health environment. ... -
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
Zeng, Xu-Fen; Varady, Krista A.; Wang, Xiang-Dong; Targher, Giovanni; Byrne, Christopher D.; Tayyem, Reema; Latella, Giovanni; Bergheim, Ina; Valenzuela, Rodrigo; George, Jacob; Newberry, Carolyn; Zheng, Ju-Sheng; George, Elena S.; Spearman, C. Wendy; Kontogianni, Meropi D.; Ristic-Medic, Danijela; Peres, Wilza Arantes Ferreira; Depboylu, Gamze Yurtdaş; Yang, Wanshui; Chen, Xu; Rosqvist, Fredrik; Mantzoros, Christos S.; Valenti, Luca; Yki-Järvinen, Hannele; Mosca, Antonella; Sookoian, Silvia; Misra, Anoop; Yılmaz, Yusuf; Kim, Won; Fouad, Yasser; Sebastiani, Giada; Wong, Vincent Wai-Sun; Åberg, Fredrik; Wong, Yu Jun; Zhang, Pianhong; Bermúdez-Silva, Francisco-Javier; Ni, Yan; Lupsor-Platon, Monica; Chan, Wah Kheong; Méndez-Sánchez, Nahum; de Knegt, Robert J.; Alam, Shahinul; Treeprasertsuk, Sombat; Wang, Li; Du, Mulong; Zhang, Tiejun; Yu, Ming-Lung; Zhang, Huijie; Qi, Xingshun; Liu, Xin; Pinyopornpanish, Kanokwan; Fan, Yu-Chen; Niu, Kaijun; Jimenez-Chillaron, Josep C.; Zheng, Ming-Hua (Elsevier, 2024)Metabolic dysfunction-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), has become the leading cause of chronic liver disease worldwide. Optimal dietary intervention ...
